PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Bioceres Crop Solutions Corp. (BIOX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINKYG1117K1141
SectorBasic Materials
IndustryAgricultural Inputs

Highlights

Market Cap$766.82M
EPS$0.35
PE Ratio36.17
Revenue (TTM)$454.53M
Gross Profit (TTM)$177.98M
EBITDA (TTM)$68.36M
Year Range$9.76 - $14.20
Target Price$20.25
Short %1.04%
Short Ratio3.87

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Bioceres Crop Solutions Corp.

Popular comparisons: BIOX vs. LOMA, BIOX vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Bioceres Crop Solutions Corp., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%NovemberDecember2024FebruaryMarchApril
18.27%
15.51%
BIOX (Bioceres Crop Solutions Corp.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Bioceres Crop Solutions Corp. had a return of -9.47% year-to-date (YTD) and 12.79% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-9.47%5.90%
1 month-2.81%-1.28%
6 months18.27%15.51%
1 year12.79%21.68%
5 years (annualized)21.03%11.74%
10 years (annualized)N/A10.50%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-2.77%-1.65%-3.58%
2023-7.84%-2.21%10.51%12.54%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of BIOX is 62, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of BIOX is 6262
Bioceres Crop Solutions Corp.(BIOX)
The Sharpe Ratio Rank of BIOX is 6464Sharpe Ratio Rank
The Sortino Ratio Rank of BIOX is 6060Sortino Ratio Rank
The Omega Ratio Rank of BIOX is 5757Omega Ratio Rank
The Calmar Ratio Rank of BIOX is 6565Calmar Ratio Rank
The Martin Ratio Rank of BIOX is 6262Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Bioceres Crop Solutions Corp. (BIOX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


BIOX
Sharpe ratio
The chart of Sharpe ratio for BIOX, currently valued at 0.35, compared to the broader market-2.00-1.000.001.002.003.000.35
Sortino ratio
The chart of Sortino ratio for BIOX, currently valued at 0.79, compared to the broader market-4.00-2.000.002.004.006.000.79
Omega ratio
The chart of Omega ratio for BIOX, currently valued at 1.09, compared to the broader market0.501.001.501.09
Calmar ratio
The chart of Calmar ratio for BIOX, currently valued at 0.31, compared to the broader market0.001.002.003.004.005.000.31
Martin ratio
The chart of Martin ratio for BIOX, currently valued at 1.01, compared to the broader market-10.000.0010.0020.0030.001.01
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.89, compared to the broader market-2.00-1.000.001.002.003.001.89
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.74, compared to the broader market-4.00-2.000.002.004.006.002.74
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.33, compared to the broader market0.501.001.501.33
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.43, compared to the broader market0.001.002.003.004.005.001.43
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.62, compared to the broader market-10.000.0010.0020.0030.007.62

Sharpe Ratio

The current Bioceres Crop Solutions Corp. Sharpe ratio is 0.35. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
0.35
1.89
BIOX (Bioceres Crop Solutions Corp.)
Benchmark (^GSPC)

Dividends

Dividend History


Bioceres Crop Solutions Corp. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2024FebruaryMarchApril
-22.31%
-3.86%
BIOX (Bioceres Crop Solutions Corp.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Bioceres Crop Solutions Corp.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Bioceres Crop Solutions Corp. was 59.41%, occurring on May 17, 2019. Recovery took 460 trading sessions.

The current Bioceres Crop Solutions Corp. drawdown is 22.31%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-59.41%Dec 13, 2018107May 17, 2019460Mar 16, 2021567
-41%Nov 18, 2021161Jul 12, 2022
-23.83%May 18, 202120Jun 15, 2021108Nov 16, 2021128
-12.51%Mar 18, 20218Mar 29, 20214Apr 5, 202112
-10.68%Apr 12, 20213Apr 14, 202110Apr 28, 202113

Volatility

Volatility Chart

The current Bioceres Crop Solutions Corp. volatility is 3.77%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2024FebruaryMarchApril
3.77%
3.39%
BIOX (Bioceres Crop Solutions Corp.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Bioceres Crop Solutions Corp. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items